Government Funds Begin To Flow For More Research On Addiction

Federal agencies welcome ideas for developing new medications to curb, treat, or prevent a host of drug addictions. WASHINGTON--The federal government is strengthening its commitment to research on drug addiction. And that means a greater demand for scientists. "We are in desperate need of both Ph.D. and M.D. clinical researchers," says Marvin Snyder, director of the Division of Preclinical Research at the National Institute on Drug Abuse (NIDA). "And we have the money." NIDA wants to develo

Written bySusan Landers
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Federal agencies welcome ideas for developing new medications to curb, treat, or prevent a host of drug addictions.
WASHINGTON--The federal government is strengthening its commitment to research on drug addiction. And that means a greater demand for scientists.

"We are in desperate need of both Ph.D. and M.D. clinical researchers," says Marvin Snyder, director of the Division of Preclinical Research at the National Institute on Drug Abuse (NIDA). "And we have the money."

NIDA wants to develop drugs to treat a range of addictions in much the same way that methadone is used to treat heroin addicts. It's the research prong of the government's overall attack on the drug epidemic that so far has consisted mainly of more prisons, more police, and more aid to countries where some of the illegal drugs are grown.

Last year NIDA funded some $31 million in addiction research, $10 million of which came from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies